PRESS RELEASE published on 08/29/2023 at 14:55, 2 years 9 months ago Amaroq Minerals Ltd. Q2 2023 Financial Results
PRESS RELEASE published on 08/23/2023 at 19:35, 2 years 10 months ago TR-1: Standard Form for Notification of Major Holdings
PRESS RELEASE published on 08/03/2023 at 19:45, 2 years 10 months ago Award of Stock Options & Block Listing Application
PRESS RELEASE published on 07/25/2023 at 17:30, 2 years 11 months ago Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them
PRESS RELEASE published on 06/16/2023 at 08:00, 3 years ago Annual General and Special Meeting ('AGM') Results
PRESS RELEASE published on 05/26/2023 at 08:00, 3 years 1 month ago 1st Quarter Financial Results and Outline of 2023 Workplan
Published on 06/26/2026 at 14:05, 3 hours 33 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 3 hours 38 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 4 hours 38 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 4 hours 53 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 17:05, 32 minutes ago NAKIKI SE Receives an Adverse Opinion on Its 2024 Financial Statements and Management Report
Published on 06/26/2026 at 17:00, 37 minutes ago Darwin AG Announces Results of the 2026 Annual General Meeting
Published on 06/26/2026 at 15:30, 2 hours 7 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 2 hours 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 07:00, 10 hours 38 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 10 hours 38 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel